A Phase 1 dose escalation study of the pharmacokinetics and tolerability of ZK 304709 , an oral multi-targeted growth inhibitor ( MTGI TM ) , in patients with advanced solid tumours
暂无分享,去创建一个
Herbert | Wiesinger | W. Steward | J. Bono | P. Fong | S. Blagden | L. R. Molife | Anne L. Thomas | E. Scott | C. McCoy | K. Kowal | Samreen Ahmed